Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Preethi.J, Puducherry, India
Kasr Al Aini, Cairo, Egypt
SUNY Downstate Medical Center, Brooklyn, New York, United States
Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
SNUH, Seoul, Jongro Gu, Korea, Republic of
Siriraj Hospital, Bangkok noi, Bangkok, Thailand
Östersund Hospital, Östersund, Jämtland, Sweden
Jubilee Mission Medical College and Research Institute, Thrissur, Kerala, India
Sir Ganga Ram Hospital, New Delhi, Delhi, India
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.